Entrada Therapeutics is focused on developing intracellular therapeutics to treat devastating diseases, particularly targeting rare diseases like Duchenne muscular dystrophy and myotonic dystrophy
Entrada Therapeutics is focused on developing intracellular therapeutics to treat devastating diseases, particularly targeting rare diseases like Duchenne muscular dystrophy and myotonic dystrophy.